Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up.AuthorsChalmers, Anna W.; Patel, Shiven; Boucher, Ken; Cannon, Laura; Esplin, Michelle; Luckart, Julie; Graves, Natalie; Van Duren, Terry; Akerley, WallacePublicationTargeted Oncology, 2019, Vol 14, Issue 4, p417ISSN1776-2596Publication typejournal articleDOI10.1007/s11523-019-00658-0